Food and Drug Administration

Dermatologic and Ophthalmic Drugs Advisory Committee

March 17, 2003



The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Vitrase® For the Treatment of Vitreous Hemorrhage, ISTA (HTM) (PPT)

Questions and Answers, ISTA (HTM) (PPT)

Vitrase (Hyaluronidase for Injection), Dr. Jennifer Harris, MD, FDA (HTM) (PPT)

Questions, FDA (HTM) (PPT)